EPIWRITE
LIVE

Serial Number

98977344

Owner

Moonwalk Biosciences

Attorney

Michael J. Allan

First Use Date

May 7, 2024

Filing Date

Feb 2, 2024

Add to watchlist:

No watchlists yet
View on USPTO

EPIWRITE Trademark

Serial Number: 98977344

EPIWRITE is a trademark filed by Moonwalk Biosciences on February 2, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Moonwalk Biosciences (8 trademarks)

2 Tower Place, 17th Floor
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

February 2, 2024

Registration Date

Not Registered

First Use Anywhere

May 7, 2024

First Use in Commerce

May 7, 2024

Published for Opposition

January 7, 2025

Goods & Services

Research and development in the field of pharmaceuticals, therapeutics, and biotechnology; Conducting research and clinical trials for others relating to pharmaceuticals in the fields of age-related, autoimmune, cardiometabolic, cardiovascular, dermatological, endocrine, epigenetic, gastrointestinal, genetic, hematological, hemoglobinopathy, immunological, infectious, liver, metabolic, muscular dystrophy, neurodegenerative, neuropsychiatric, oncological, ophthalmological, pediatric, psychiatric, pulmonary, renal, reproductive, respiratory, and skeletal diseases; Conducting research and clinical trials for others relating to veterinary pharmaceuticals in the fields of age-related, autoimmune, cardiometabolic, cardiovascular, dermatological, endocrine, epigenetic, gastrointestinal, genetic, hematological, hemoglobinopathy, immunological, infectious, liver, metabolic, muscular dystrophy, neurodegenerative, neuropsychiatric, oncological, ophthalmological, psychiatric, pulmonary, renal, reproductive, respiratory, and skeletal diseases

Filing History

NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 3, 2026 GNFN
FINAL REFUSAL E-MAILED
Feb 3, 2026 GNFR
SU - FINAL REFUSAL - WRITTEN
Feb 3, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 3, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 3, 2026 CRFA
ASSIGNED TO LIE
Feb 3, 2026 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 27, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 6, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 6, 2026 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jan 6, 2026 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jan 5, 2026 SUPC
DIVISIONAL PROCESSING COMPLETE
Jan 5, 2026 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 5, 2026 AITU
USE AMENDMENT FILED
Jul 11, 2025 IUAF
DIVISIONAL REQUEST RECEIVED
Jul 11, 2025 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jul 11, 2025 ERTD
TEAS STATEMENT OF USE RECEIVED
Jul 11, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 4, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 7, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 12, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 12, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 12, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 12, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 12, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 30, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 30, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 27, 2024 GNFN
FINAL REFUSAL E-MAILED
Aug 27, 2024 GNFR
FINAL REFUSAL WRITTEN
Aug 27, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 19, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 19, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 19, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 23, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 23, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 23, 2024 CNRT
ASSIGNED TO EXAMINER
May 22, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 29, 2024 NWOS
NEW APPLICATION ENTERED
Feb 6, 2024 NWAP